COMBINATION OF A COMPOUND HAVING THE ABILITY TO REARRANGE A LYSOSOMAL ENZYME AND AMBROXOL AND/OR A DERIVATIVE OF AMBROXOL
申请人:Centogene IP GmbH
公开号:EP2793872B1
公开(公告)日:2021-03-10
Combination of a Compound Having the Ability to Rearrange a Lysosomal Enzyme and Ambroxol and/or a Derivative of Ambroxol
申请人:Centogene IP GmbH
公开号:US20210228560A1
公开(公告)日:2021-07-29
The present invention is related to a combination comprising a first constituent and a second constituent, wherein the first constituent is a compound having the ability to rearrange a lysosomal protein, wherein the lysosomal protein has a reduced activity, and wherein the second constituent is Ambroxol and/or a derivative of Ambroxol.
[EN] COMBINATION OF A COMPOUND HAVING THE ABILITY TO REARRANGE A LYSOSOMAL ENZYME AND AMBROXOL AND/OR A DERIVATIVE OF AMBROXOL<br/>[FR] COMBINAISON D'UN COMPOSÉ AYANT L'APTITUDE À RÉARRANGER UNE ENZYME LYSOSOMALE ET D'AMBROXOL ET/OU D'UN DÉRIVÉ D'AMBROXOL
申请人:CENTOGENE GMBH
公开号:WO2013091897A1
公开(公告)日:2013-06-27
It is herewith declared that the information stored on the carrier which is submitted together with the international patent application is identical to the written sequence listing of the international patent application.